JAK inhibitors may increase risk for herpes zoster in patients with IBD

Patients with inflammatory bowel disease and other immune-mediated diseases who receive Janus kinase inhibitors may be at increased risk for herpes zoster infection, according to the results of a meta-analysis.Laurent Peyrin-Biroulet, MD, PhD, of the department of hepatogastroenterology at Nancy University Hospital in France, and colleagues wrote that as the number of new treatments for IBD grows, decisions about how to position them become more difficult.“With an increasing therapeutic armamentarium, treatment algorithms in IBD will become more complex, with several drug classes andRead More

Share on facebook
Share on twitter
Share on linkedin